title: Prenatal toxicity of acyclovir in rats.
abstract: Pregnant rats were treated during organogenesis with s.c. injections of acyclovir and the embryos were evaluated on day 11.5 of gestation (crown-rump length, somites, protein content, score, abnormalities, histological examination). After eight injections of 50 mg/kg body wt on days 9, 10, and 11 of pregnancy a reduction of the crown-rump length was noticed. After 100 mg/kg this effect was more pronounced. With two or three applications of this dose on day 10 specific embryonic abnormalities were visible: the shape of the head was abnormal, the width of the skull had decreased resembling a beak-like visceral cranium. With a single administration of 200 mg/kg on day 10 we found a similar but slightly more pronounced outcome. A drastic change of all variables was obtained after eight injections of 100 mg/kg on days 9, 10, and 11. Comparatively we measured maternal plasma concentrations of acyclovir 1 h after the administration of 50, 100 or 200 mg/kg body wt. After an injection of 50 mg/kg on days 9, 10, and 11 of gestation (three injections/day) the plasma levels ranged from 19.1 to 40.0 mg/l (1 mg/l = 4.44 microM). No cumulation was observed. In contrast, a cumulative effect was detected following a dose of 100 mg/kg. After the first injection of this dose a mean value (+/- SD) of 60.3 +/- 14.7 mg/l (n = 16) was obtained. In this case a third injection increased the mean plasma level to 124.6 +/- 16.6 mg/l (n = 5). Further injections, however, led to decreasing levels. One hour after administration of 200 mg/kg body wt acyclovir levels ranged from 120.0 to 163.9 mg/l. We conclude that acyclovir, at doses leading to plasma concentrations well above the therapeutic level in the dam, interferes with the embryonic development in the rat. Acyclovir induces typical gross structural abnormalities which have been first observed using a whole embryo culture system.
authors.affiliation: Institut für Toxikologie und Embryopharmakologie, Freie Universität Berlin.
authors.forename: R
authors.initials: R
authors.lastname: Stahlmann
authors.forename: S
authors.initials: S
authors.lastname: Klug
authors.forename: C
authors.initials: C
authors.lastname: Lewandowski
authors.forename: G
authors.initials: G
authors.lastname: Bochert
authors.forename: I
authors.initials: I
authors.lastname: Chahoud
authors.forename: U
authors.initials: U
authors.lastname: Rahm
authors.forename: H J
authors.initials: HJ
authors.lastname: Merker
authors.forename: D
authors.initials: D
authors.lastname: Neubert
mesh_terms: D000212:Acyclovir / Q000493:pharmacokinetics / Q000633:toxicity*; D000818:Animals; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D005260:Female; D011247:Pregnancy; D051381:Rats; D013723:Teratogens
chemical_list: D013723:Teratogens; D000212:Acyclovir